JonathanCBritellMD

Oncology • Renton, WA

Physician

Join to view full profile

Dr. Britell is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Britell's full profile

Already have an account?

Office
3915 Talbot Rd S
Suite 300
Renton, WA 98055
Phone+1 425-656-5570

Fax+1 425-656-5280
Is this information wrong?

Education & Training

Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Hematology and Medical Oncology, 1977 - 1979
Oregon Health & Science UniversityFellowship, Hematology and Medical Oncology, 1976 - 1977
Oregon Health & Science UniversityResidency, Internal Medicine, 1974 - 1976
University of Southern California/LAC+USC Medical CenterInternship, Internal Medicine, 1973 - 1974
Albany Medical CollegeClass of 1973

Certifications & Licensure

WA State Medical License 1985 - 2024
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012
Fellow (FACP) American College of Physicians, 2011

Publications & Presentations

PubMed

13 citations
Role of Advanced Nurse Practitioners and Physician Assistants in Washington State
Jonathan C. Britell> ;Journal of Oncology Practice. 2010 Jan 1
Phase II trial of iv 6-thioguanine in advanced colorectal carcinoma.
Britell, J. C., Moertel, C. G., Kvols, L. K., O'Connell, M. J., Rubin, J., Schutt, A. J.> ;Cancer Treat Rep. 1981 Sep 01
Phase II trial of indicine N-oxide (INDI) in patients with advanced colorectal carcinoma.
Nichols, W. C., Moertel, C. G., Rubin, J., Schutt, A. J., Britell, J. C.> ;Cancer Treat Rep. 1981 Mar 01
Phase II study of PALA in advanced large bowel carcinoma.
Rubin, J., Purvis, J., Britell, J. C., Hahn, R. G., Moertel, C. G., Schutt, A. J.> ;Cancer Treat Rep. 1981 Mar 01
Wilms'' tumor. Effect of chemotherapy on survival.
Britell, J. C., Olson, K. B., Horton, J., Baxter, D.> ;N Y State J Med. 1972 Oct 01
cis-Dichlorodiammineplatinum(II) alone followed by adriamycin plus cyclophosphamide at progression versus cis-dichlorodiammineplatinum(II), adriamycin, and cyclophosph...
Britell, J. C., Eagan, R. T., Ingle, J. N., Creagen, E. T., Rubin, J., Frytak, S.> ;Cancer Treat Rep. 1978 Aug
Treatment of advanced breast cancer with cyclophosphamide, 5-fluorouracil, and prednisone with and without methanol-extracted residue of BCG.
Britell, J. C., Ahmann, D. L., Bisel, H. F., Frytak, S., Ingle, J. N., Rubin, J., O'Fallon, J. R.> ;Cancer Clin Trials. 1979
VP-16-213 and cyclophosphamide in small cell lung cancer: a long-term followup report.
Britell, J. C., Eagan, R. T., Lee, R. E.> ;Cancer Treat Rep. 1979 Nov 01
Join now to see all

Professional Memberships

American Society of Clinical Oncology - ASCO
Member
American College of Physicians - ACP
Fellow